StreetInsider.com News Articles

A new era for surgery with real-time AI: Medtronic to unveil Touch Surgery™ Aide, the next-generation compute platform for the operating room at Society of Robotic Surgery 2026

Tue, 21 Jul 2026 07:00:00 -0400

Advanced compute power, built on NVIDIA infrastructure, enables real-time decision support during the procedure

FDA-cleared Instrument Exit Point (IEP), the first real-time AI application for robotic procedures from Medtronic, advances a precise, predictable, and personalized future for surgery

GALWAY, Ireland, July 21, 2026 /PRNewswire/ -- Medtronic (NYSE: MDT), a global leader in healthcare technology, is presenting an early look at its next-generation compute platform for the operating room. Touch Surgery™ Aide — an AI-native surgical computing platform that powers the Touch Surgery™ ecosystem — enables real-time artificial intelligence during procedures. Touch Surgery™ Aide will be shared at the

A new era for surgery with real-time AI: Medtronic to unveil Touch Surgery™ Aide, the next-generation compute platform for the operating room at Society of Robotic Surgery 2026

Tue, 21 Jul 2026 07:00:00 -0400

Advanced compute power, built on NVIDIA infrastructure, enables real-time decision support during the procedure

FDA-cleared Instrument Exit Point (IEP), the first real-time AI application for robotic procedures from Medtronic, advances a precise, predictable, and personalized future for surgery

A new era for surgery with real-time AI: Medtronic to unveil Touch Surgery™ Aide, the next-generation compute platform for the operating room at Society of Robotic Surgery 2026

Tue, 21 Jul 2026 07:00:00 -0400

Advanced compute power, built on NVIDIA infrastructure, enables real-time decision support during the procedure

FDA-cleared Instrument Exit Point (IEP), the first real-time AI application for robotic procedures from Medtronic, advances a precise, predictable, and personalized future for surgery

A new era for surgery with real-time AI: Medtronic to unveil Touch Surgery™ Aide, the next-generation compute platform for the operating room at Society of Robotic Surgery 2026

Tue, 21 Jul 2026 07:00:00 -0400

Advanced compute power, built on NVIDIA infrastructure, enables real-time decision support during the procedure

FDA-cleared Instrument Exit Point (IEP), the first real-time AI application for robotic procedures from Medtronic, advances a precise, predictable, and personalized future for surgery

A new era for surgery with real-time AI: Medtronic to unveil Touch Surgery™ Aide, the next-generation compute platform for the operating room at Society of Robotic Surgery 2026

Tue, 21 Jul 2026 07:00:00 -0400

Advanced compute power, built on NVIDIA infrastructure, enables real-time decision support during the procedure

FDA-cleared Instrument Exit Point (IEP), the first real-time AI application for robotic procedures from Medtronic, advances a precise, predictable, and personalized future for surgery

A new era for surgery with real-time AI: Medtronic to unveil Touch Surgery™ Aide, the next-generation compute platform for the operating room at Society of Robotic Surgery 2026

Tue, 21 Jul 2026 07:00:00 -0400

Advanced compute power, built on NVIDIA infrastructure, enables real-time decision support during the procedure

FDA-cleared Instrument Exit Point (IEP), the first real-time AI application for robotic procedures from Medtronic, advances a precise, predictable, and personalized future for surgery

A new era for surgery with real-time AI: Medtronic to unveil Touch Surgery™ Aide, the next-generation compute platform for the operating room at Society of Robotic Surgery 2026

Tue, 21 Jul 2026 07:00:00 -0400

Advanced compute power, built on NVIDIA infrastructure, enables real-time decision support during the procedure

FDA-cleared Instrument Exit Point (IEP), the first real-time AI application for robotic procedures from Medtronic, advances a precise, predictable, and personalized future for surgery

A new era for surgery with real-time AI: Medtronic to unveil Touch Surgery™ Aide, the next-generation compute platform for the operating room at Society of Robotic Surgery 2026

Tue, 21 Jul 2026 07:00:00 -0400

Advanced compute power, built on NVIDIA infrastructure, enables real-time decision support during the procedure

FDA-cleared Instrument Exit Point (IEP), the first real-time AI application for robotic procedures from Medtronic, advances a precise, predictable, and personalized future for surgery

A new era for surgery with real-time AI: Medtronic to unveil Touch Surgery™ Aide, the next-generation compute platform for the operating room at Society of Robotic Surgery 2026

Tue, 21 Jul 2026 07:00:00 -0400

Advanced compute power, built on NVIDIA infrastructure, enables real-time decision support during the procedure

FDA-cleared Instrument Exit Point (IEP), the first real-time AI application for robotic procedures from Medtronic, advances a precise, predictable, and personalized future for surgery

A new era for surgery with real-time AI: Medtronic to unveil Touch Surgery™ Aide, the next-generation compute platform for the operating room at Society of Robotic Surgery 2026

Tue, 21 Jul 2026 07:00:00 -0400

Advanced compute power, built on NVIDIA infrastructure, enables real-time decision support during the procedure

FDA-cleared Instrument Exit Point (IEP), the first real-time AI application for robotic procedures from Medtronic, advances a precise, predictable, and personalized future for surgery

A new era for surgery with real-time AI: Medtronic to unveil Touch Surgery™ Aide, the next-generation compute platform for the operating room at Society of Robotic Surgery 2026

Tue, 21 Jul 2026 07:00:00 -0400

Advanced compute power, built on NVIDIA infrastructure, enables real-time decision support during the procedure

FDA-cleared Instrument Exit Point (IEP), the first real-time AI application for robotic procedures from Medtronic, advances a precise, predictable, and personalized future for surgery

A new era for surgery with real-time AI: Medtronic to unveil Touch Surgery™ Aide, the next-generation compute platform for the operating room at Society of Robotic Surgery 2026

Tue, 21 Jul 2026 07:00:00 -0400

Advanced compute power, built on NVIDIA infrastructure, enables real-time decision support during the procedure

FDA-cleared Instrument Exit Point (IEP), the first real-time AI application for robotic procedures from Medtronic, advances a precise, predictable, and personalized future for surgery

Medtronic to announce financial results for its first quarter of fiscal year 2027

Mon, 20 Jul 2026 07:00:00 -0400

GALWAY, Ireland, July 20, 2026 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that it will report financial results on Tuesday, September 1, 2026, for its first quarter of fiscal year 2027, which ends on Friday, July 31, 2026.

A news release containing summary financial information will be issued at 5:45 a.m. Central Time (CT) and will be available at https://news.medtronic.com.
A video webcast to discuss results will begin at 6:45 a.m. CT and can be accessed at

Medtronic to announce financial results for its first quarter of fiscal year 2027

Mon, 20 Jul 2026 07:00:00 -0400

GALWAY, Ireland, July 20, 2026 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that it will report financial results on Tuesday, September 1, 2026, for its first quarter of fiscal year 2027, which ends on Friday, July 31, 2026.
A news release containing summary financial information will be issued at 5:45 a.m. Central Time (CT) and will be available at https://news.medtronic.com.
A video webcast to discuss results will begin at 6:45 a.m. CT and can be accessed at

Medtronic to announce financial results for its first quarter of fiscal year 2027

Mon, 20 Jul 2026 07:00:00 -0400

GALWAY, Ireland, July 20, 2026 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that it will report financial results on Tuesday, September 1, 2026, for its first quarter of fiscal year 2027, which ends on Friday, July 31, 2026.
A news release containing summary financial information will be issued at 5:45 a.m. Central Time (CT) and will be available at https://news.medtronic.com.
A video webcast to discuss results will begin at 6:45 a.m. CT and can be accessed at

Medtronic to announce financial results for its first quarter of fiscal year 2027

Mon, 20 Jul 2026 07:00:00 -0400

GALWAY, Ireland, July 20, 2026 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that it will report financial results on Tuesday, September 1, 2026, for its first quarter of fiscal year 2027, which ends on Friday, July 31, 2026.
A news release containing summary financial information will be issued at 5:45 a.m. Central Time (CT) and will be available at https://news.medtronic.com.
A video webcast to discuss results will begin at 6:45 a.m. CT and can be accessed at

Medtronic acquires SPR Therapeutics for $650 million

Thu, 16 Jul 2026 09:01:32 -0400

Medtronic plc (NYSE: MDT) announced it has completed the acquisition of SPR Therapeutics, Inc., a privately held medical technology company, for $650 million in an upfront cash payment.

SPR makes the FDA-cleared SPRINT® Peripheral Nerve Stimulation (PNS) System, a 60-day, minimally invasive treatment for chronic and acute pain that does not require a permanent implant. The system delivers mild electrical stimulation near targeted peripheral nerves and is positioned as a non-opioid, non-surgical therapy.

According to pooled results from 13 clinical studies cited in the press release, 60% of patients achieved at least a 50% reduction in pain intensity at the end of

Medtronic acquires SPR Therapeutics for $650 million

Thu, 16 Jul 2026 09:01:32 -0400

Medtronic plc (NYSE: MDT) announced it has completed the acquisition of SPR Therapeutics, Inc., a privately held medical technology company, for $650 million in an upfront cash payment.

SPR makes the FDA-cleared SPRINT® Peripheral Nerve Stimulation (PNS) System, a 60-day, minimally invasive treatment for chronic and acute pain that does not require a permanent implant. The system delivers mild electrical stimulation near targeted peripheral nerves and is positioned as a non-opioid, non-surgical therapy.

According to pooled results from 13 clinical studies cited in the press release, 60% of patients achieved at least a 50% reduction in pain intensity at the end of

Medtronic completes acquisition of SPR, expanding patient access to minimally invasive, non-opioid treatment of chronic and acute pain

Thu, 16 Jul 2026 09:00:00 -0400

Acquisition adds category-defining SPRINT® PNS technology to Medtronic's pain therapy portfolio—the broadest in the industry.¹
GALWAY, Ireland, July 16, 2026 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced it has completed its acquisition of SPR Therapeutics, Inc. (SPR), a privately held medical technology company and recognized leader in short-term, percutaneous peripheral nerve stimulation (PNS) therapies for chronic and acute pain management. The acquisition is valued at $650 million, consisting of an upfront cash payment.
Chronic pain affects nearly 50 million U.S. adults², and for

Medtronic completes acquisition of SPR, expanding patient access to minimally invasive, non-opioid treatment of chronic and acute pain

Thu, 16 Jul 2026 09:00:00 -0400

Acquisition adds category-defining SPRINT® PNS technology to Medtronic's pain therapy portfolio—the broadest in the industry.¹
GALWAY, Ireland, July 16, 2026 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced it has completed its acquisition of SPR Therapeutics, Inc. (SPR), a privately held medical technology company and recognized leader in short-term, percutaneous peripheral nerve stimulation (PNS) therapies for chronic and acute pain management. The acquisition is valued at $650 million, consisting of an upfront cash payment.
Chronic pain affects nearly 50 million U.S. adults², and for

Medtronic completes acquisition of SPR, expanding patient access to minimally invasive, non-opioid treatment of chronic and acute pain

Thu, 16 Jul 2026 09:00:00 -0400

Acquisition adds category-defining SPRINT® PNS technology to Medtronic's pain therapy portfolio—the broadest in the industry.¹
GALWAY, Ireland, July 16, 2026 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced it has completed its acquisition of SPR Therapeutics, Inc. (SPR), a privately held medical technology company and recognized leader in short-term, percutaneous peripheral nerve stimulation (PNS) therapies for chronic and acute pain management. The acquisition is valued at $650 million, consisting of an upfront cash payment.
Chronic pain affects nearly 50 million U.S. adults², and for

Medtronic completes acquisition of SPR, expanding patient access to minimally invasive, non-opioid treatment of chronic and acute pain

Thu, 16 Jul 2026 09:00:00 -0400

Acquisition adds category-defining SPRINT® PNS technology to Medtronic's pain therapy portfolio—the broadest in the industry.¹
GALWAY, Ireland, July 16, 2026 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced it has completed its acquisition of SPR Therapeutics, Inc. (SPR), a privately held medical technology company and recognized leader in short-term, percutaneous peripheral nerve stimulation (PNS) therapies for chronic and acute pain management. The acquisition is valued at $650 million, consisting of an upfront cash payment.
Chronic pain affects nearly 50 million U.S. adults², and for

Medical device stocks tumble after HCA flags weak surgical volumes

Tue, 14 Jul 2026 14:23:42 -0400

Investing.com -- Shares of major medical device manufacturers fell Tuesday after hospital operator HCA Healthcare (NYSE:HCA) posted preliminary second quarter results showing weaker-than-expected surgical volumes.
GE Healthcare (NASDAQ:GEHC) dropped 7%, while Intuitive Surgical (NASDAQ:ISRG) declined 6%. Stryker (NYSE:SYK) fell 5.4%, Globus Medical (NYSE:GMED) slid 5.25%, and Medtronic (NYSE:MDT) dropped 4.7%. Boston Scientific (NYSE:BSX), Baxter International (NYSE:BAX), and Tandem Diabetes (NASDAQ:TNDM) each fell 4%, while Zimmer Biomet (NYSE:ZBH) declined 3% and Inspire Medical (NYSE:INSP) dropped 3.75%.
HCA Healthcare's preliminary results highlighted softer surgical procedure volumes during the quarter, raising concerns about demand for medical devices and equipment across the healthcare sector.
Wells Fargo analyst

Medical device stocks tumble after HCA flags weak surgical volumes

Tue, 14 Jul 2026 14:23:42 -0400

Investing.com -- Shares of major medical device manufacturers fell Tuesday after hospital operator HCA Healthcare (NYSE:HCA) posted preliminary second quarter results showing weaker-than-expected surgical volumes.
GE Healthcare (NASDAQ:GEHC) dropped 7%, while Intuitive Surgical (NASDAQ:ISRG) declined 6%. Stryker (NYSE:SYK) fell 5.4%, Globus Medical (NYSE:GMED) slid 5.25%, and Medtronic (NYSE:MDT) dropped 4.7%. Boston Scientific (NYSE:BSX), Baxter International (NYSE:BAX), and Tandem Diabetes (NASDAQ:TNDM) each fell 4%, while Zimmer Biomet (NYSE:ZBH) declined 3% and Inspire Medical (NYSE:INSP) dropped 3.75%.
HCA Healthcare's preliminary results highlighted softer surgical procedure volumes during the quarter, raising concerns about demand for medical devices and equipment across the healthcare sector.
Wells Fargo analyst

Medical device stocks tumble after HCA flags weak surgical volumes

Tue, 14 Jul 2026 14:23:42 -0400

Investing.com -- Shares of major medical device manufacturers fell Tuesday after hospital operator HCA Healthcare (NYSE:HCA) posted preliminary second quarter results showing weaker-than-expected surgical volumes.
GE Healthcare (NASDAQ:GEHC) dropped 7%, while Intuitive Surgical (NASDAQ:ISRG) declined 6%. Stryker (NYSE:SYK) fell 5.4%, Globus Medical (NYSE:GMED) slid 5.25%, and Medtronic (NYSE:MDT) dropped 4.7%. Boston Scientific (NYSE:BSX), Baxter International (NYSE:BAX), and Tandem Diabetes (NASDAQ:TNDM) each fell 4%, while Zimmer Biomet (NYSE:ZBH) declined 3% and Inspire Medical (NYSE:INSP) dropped 3.75%.
HCA Healthcare's preliminary results highlighted softer surgical procedure volumes during the quarter, raising concerns about demand for medical devices and equipment across the healthcare sector.
Wells Fargo analyst

StreetInsider.com News Articles

A new era for surgery with real-time AI: Medtronic to unveil Touch Surgery™ Aide, the next-generation compute platform for the operating room at Society of Robotic Surgery 2026

A new era for surgery with real-time AI: Medtronic to unveil Touch Surgery™ Aide, the next-generation compute platform for the operating room at Society of Robotic Surgery 2026

A new era for surgery with real-time AI: Medtronic to unveil Touch Surgery™ Aide, the next-generation compute platform for the operating room at Society of Robotic Surgery 2026

A new era for surgery with real-time AI: Medtronic to unveil Touch Surgery™ Aide, the next-generation compute platform for the operating room at Society of Robotic Surgery 2026

A new era for surgery with real-time AI: Medtronic to unveil Touch Surgery™ Aide, the next-generation compute platform for the operating room at Society of Robotic Surgery 2026

A new era for surgery with real-time AI: Medtronic to unveil Touch Surgery™ Aide, the next-generation compute platform for the operating room at Society of Robotic Surgery 2026

A new era for surgery with real-time AI: Medtronic to unveil Touch Surgery™ Aide, the next-generation compute platform for the operating room at Society of Robotic Surgery 2026

A new era for surgery with real-time AI: Medtronic to unveil Touch Surgery™ Aide, the next-generation compute platform for the operating room at Society of Robotic Surgery 2026

A new era for surgery with real-time AI: Medtronic to unveil Touch Surgery™ Aide, the next-generation compute platform for the operating room at Society of Robotic Surgery 2026

A new era for surgery with real-time AI: Medtronic to unveil Touch Surgery™ Aide, the next-generation compute platform for the operating room at Society of Robotic Surgery 2026

A new era for surgery with real-time AI: Medtronic to unveil Touch Surgery™ Aide, the next-generation compute platform for the operating room at Society of Robotic Surgery 2026

A new era for surgery with real-time AI: Medtronic to unveil Touch Surgery™ Aide, the next-generation compute platform for the operating room at Society of Robotic Surgery 2026

Medtronic to announce financial results for its first quarter of fiscal year 2027

Medtronic to announce financial results for its first quarter of fiscal year 2027

Medtronic to announce financial results for its first quarter of fiscal year 2027

Medtronic to announce financial results for its first quarter of fiscal year 2027

Medtronic acquires SPR Therapeutics for $650 million

Medtronic acquires SPR Therapeutics for $650 million

Medtronic completes acquisition of SPR, expanding patient access to minimally invasive, non-opioid treatment of chronic and acute pain

Medtronic completes acquisition of SPR, expanding patient access to minimally invasive, non-opioid treatment of chronic and acute pain

Medtronic completes acquisition of SPR, expanding patient access to minimally invasive, non-opioid treatment of chronic and acute pain

Medtronic completes acquisition of SPR, expanding patient access to minimally invasive, non-opioid treatment of chronic and acute pain

Medical device stocks tumble after HCA flags weak surgical volumes

Medical device stocks tumble after HCA flags weak surgical volumes

Medical device stocks tumble after HCA flags weak surgical volumes